Biocorrx Stock Today
| BICX Stock | USD 0.30 0.06 16.67% |
Performance4 of 100
| Odds Of DistressOver 84
|
BioCorRx is trading at 0.3 as of the 28th of November 2024; that is 16.67 percent decrease since the beginning of the trading day. The stock's open price was 0.36. BioCorRx has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for BioCorRx are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. The company has 7.63 M outstanding shares. More on BioCorRx
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioCorRx OTC Stock Highlights
| CEO | Brady Granier |
| Business Concentration | Medical Care Facilities, Healthcare (View all Sectors) |
BioCorRx [BICX] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioCorRx's market, we take the total number of its shares issued and multiply it by BioCorRx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioCorRx conducts business under Healthcare sector and is part of Medical Care Facilities industry. The entity has 7.63 M outstanding shares.
BioCorRx currently holds about 81.76 K in cash with (3.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check BioCorRx Probability Of Bankruptcy
Ownership AllocationThe market capitalization of BioCorRx is $11.82 Million. BioCorRx retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check BioCorRx Ownership Details
BioCorRx Risk Profiles
| Mean Deviation | 4.81 | |||
| Semi Deviation | 7.46 | |||
| Standard Deviation | 12.59 | |||
| Variance | 158.6 |
BioCorRx Stock Against Markets
Picking the right benchmark for BioCorRx otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BioCorRx otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BioCorRx is critical whether you are bullish or bearish towards BioCorRx at a given time. Please also check how BioCorRx's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioCorRx without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Additional Tools for BioCorRx OTC Stock Analysis
When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.